-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RNS-60 in Acute Ischemic Stroke
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RNS-60 in Acute Ischemic Stroke report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. RNS-60 in Acute Ischemic Stroke Drug Details: RNS-60 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RNS-60 in Amyotrophic Lateral Sclerosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RNS-60 in Amyotrophic Lateral Sclerosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. RNS-60 in Amyotrophic Lateral Sclerosis Drug Details: RNS-60 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CNMAU-8 in Relapsing Multiple Sclerosis (RMS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CNMAU-8 in Relapsing Multiple Sclerosis (RMS) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CNMAU-8 in Relapsing Multiple Sclerosis (RMS) Drug Details: CNMAU-8 is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – CNMAU-8 in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CNMAU-8 in Parkinson's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CNMAU-8 in Parkinson's Disease Drug Details: CNMAU-8 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CNMAU-8 in Secondary Progressive Multiple Sclerosis (SPMS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CNMAU-8 in Secondary Progressive Multiple Sclerosis (SPMS) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CNMAU-8 in Secondary Progressive Multiple Sclerosis (SPMS) Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CNMAU-8 in Amyotrophic Lateral Sclerosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CNMAU-8 in Amyotrophic Lateral Sclerosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CNMAU-8 in Amyotrophic Lateral Sclerosis Drug Details: CNMAU-8 is under development...
-
Sector Analysis
Iron Ore Mining Market Analysis by Reserves, Production, Assets, Demand Drivers and Forecast to 2030
Empower your strategies with our Global Iron Ore Mining to 2026 report and make more profitable business decisions.Iron Ore Mining Market Report Overview The iron ore production was 2,398.3Mt in 2023 with Brazil, China, Russia, India, and Australia being the key contributors. The iron ore production is expected to grow marginally at a CAGR of more than 1% over the forecast period. Iron Ore Mining Market Outlook, 2023 – 2030 (Mt) Buy the Full Report for More Insights into the...
-
Sector Analysis
Brazil Iron Ore Mining Market by Reserves, Production, Assets, Projects, Fiscal Regime with Taxes, Royalties and Forecast to 2030
Empower your strategies with our Brazil Iron Ore Mining to 2026 report and make more profitable business decisions.Brazil Iron Ore Mining Market Report Overview Brazil is the world’s second-largest iron ore producer, after Australia. In 2023, the iron ore mine production output in Brazil was 410.2 million tonnes (Mt). The iron ore production in Brazil will grow at a CAGR of more than 2% from 2024 to 2030. This growth is in line with Vale’s target to produce between 340-360Mt...
-
Company Profile
Companhia Siderurgica Nacional – Company Profile
Companhia Siderurgica Nacional (CSN) is a producer of steel and related products. The company offers flat steel, long steel, cold-rolled products, hot-rolled products, light-gauge hot-rolled coils and sheets, and galvanized products. It carries out mining and casting of iron ore, dolomite, limestone, and tin. It also manufactures cement and operates thermoelectric cogeneration power plant and hydroelectric power plants. CSN operates terminals in the Port of Itaguai, in Rio de Janeiro. The company supplies its products to various industries including automobile,...
Add to Basket